| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.0026 | 1 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |